Form 4 Filing: BIENAIME JEAN JACQUES Sells shares of $ASND

INSIDER SALE

⚡ MATERIALITY: 3/10

corporate issuer

Ascendis Pharma A/S

Ticker: $ASND

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-04-14

Shares: 18,320

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BIENAIME JEAN JACQUES, holds the title of Director at Ascendis Pharma A/S.

On 2026-04-14, the insider transacted 18,320 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

BIENAIME JEAN JACQUES (Director) sold $0 of $ASND

Post-Transaction Position: 0 shares

SEC Accession No: 0001610717-26-000423 (CIK: 1221590)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ASND Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ASND News Coverage